Related Experiment Video
Updated: Jan 15, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Dentists' knowledge, attitudes, and practices regarding antithrombotic drugs: pre-post test study
Fatıma Ulya Yürük1,2, Songül Tezcan3, Ayşenur Cengiz4
1Hamidiye Faculty of Pharmacy, Clinical Pharmacy, University of Health Sciences, Istanbul, Türkiye. ulyayuruk1995@gmail.com.
Clinical pharmacist training significantly improved dentists' knowledge and attitudes regarding antithrombotic medications. This enhanced understanding helps manage bleeding risks in dental patients on these crucial drugs.
Area of Science:
- Dental Pharmacology
- Clinical Pharmacy
- Patient Safety
Background:
- Managing patients on antithrombotic medications in dentistry is critical for preventing bleeding and thrombosis.
- Dentists require updated knowledge and practices for safe patient care.
Purpose of the Study:
- To assess the impact of clinical pharmacist-led training on dentists' understanding of antithrombotic drugs.
- To evaluate changes in dentists' knowledge, attitudes, and practices concerning antithrombotic therapy.
Main Methods:
- A pre-post test design was employed in dental health centers.
- A 49-item questionnaire assessed dentists' knowledge and attitudes before and after a 45-minute training session.
- 238 dentists participated in the study.
Main Results:
- Dentists' baseline knowledge of antithrombotic drugs was low (13.2%), significantly increasing to 91.7% post-training.
- Post-training, 89.3% of dentists correctly understood aspirin management for dental procedures, up from 13.2%.
- Understanding of warfarin management improved significantly, with correct responses rising from 13.2% to 55.6%.
Conclusions:
- Clinical pharmacist training demonstrably enhances dentists' knowledge and attitudes towards antithrombotic medications.
- Improved understanding can lead to safer dental management of patients on antithrombotic therapy.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Atherosclerosis III: Management

